Andreas Harstrick
Chief Executive Officer at AFFIMED N.V.
Net worth: 213 765 $ as of 30/03/2024
Profile
Andreas Harstrick is currently the Chief Executive & Medical Officer at Affimed NV.
He previously worked as a Director at Lilly Oncology.
From 2008 to 2014, he was the Senior Vice President-Medical Sciences at ImClone LLC.
He also served as the Chief Medical Officer at Molecular Partners AG from 2015 to 2019.
Prior to that, he held the position of SVP-Global Clinical Development Unit Oncology at Merck Serono Ltd.
from 1998 to 2008.
Dr. Harstrick's education includes a doctorate degree from the University of Hannover in 1986.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AFFIMED N.V.
0.27% | 14/03/2023 | 40,333 ( 0.27% ) | 213 765 $ | 30/03/2024 |
Andreas Harstrick active positions
| Companies | Position | Start |
|---|---|---|
| AFFIMED N.V. | Chief Executive Officer | 14/01/2024 |
Former positions of Andreas Harstrick
| Companies | Position | End |
|---|---|---|
| MOLECULAR PARTNERS AG | Chief Tech/Sci/R&D Officer | 31/08/2019 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 31/12/2013 |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | 31/12/2007 |
| University of Duisburg-Essen | Corporate Officer/Principal | - |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Director/Board Member | - |
Training of Andreas Harstrick
| University of Hannover | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AFFIMED N.V. | Health Technology |
| MOLECULAR PARTNERS AG | Health Technology |
| Private companies | 3 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Health Services |
- Stock Market
- Insiders
- Andreas Harstrick
